Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Kariminejad - |
RCV001814542 | SCV001755577 | likely pathogenic | Abnormality of the musculature | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV003127986 | SCV003802857 | uncertain significance | not provided | 2022-12-15 | criteria provided, single submitter | clinical testing | The FHL1 c.461A>C (p.His154Pro) missense variant results in the substitution of histidine at amino acid position 154 with proline. The c.461A>C variant has been reported in one family with six affected individuals with FHL1-related disorders; however, the genotypes and phenotypes of most family members were not provided (PMID: 27234031). The proband described was a 35-year-old heterozygous female with proximal muscle weakness, difficulty climbing stairs, and elevated CK level; it was noted that hemizygous males in the family had a more severe phenotype with earlier age of onset (PMID: 27234031). This variant is not found in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. The c.461A>C variant was identified in a hemizygous state in the proband. Based on the available evidence, the c.461A>C (p.His154Pro) variant is classified as a variant of uncertain significance for FHL1-related disorders. |